Syrian Extremists 'Grave' Security Threat: Holder

July 8 (Bloomberg) -- Bloomberg’s Phil Mattingly reports on Attorney General Eric Holder unveils a new plan to confront the growing threat of terrorist attacks from the Middle East. He speaks with Betty Liu on “In The Loop.” (Source: Bloomberg)

Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month
09:46 - Pfizer and Merck KGaA’s cancer immunotherapy won approval from U.S. regulators for patients with a rare form of skin cancer, and the companies plan to sell the drug for $13,000 a month. Merck KgaA CEO Stegfan Oschmann speaks on "Bloomberg Daybreak Europe." (Source: Bloomberg)
  • Aviva's Diebel Sees No Macro Impact From Healthcare Bill
  • Italy Junior Minister Sees Brexit as EU Opportunity
  • French Presidential Race Takes an Inflammatory Turn